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Abstract
The transient receptor potential M2 channel (TRPM2) is the Ca 2+ -permeable cation channel controlled by cellular redox status via -NAD + and ADP-ribose (ADPR).
TRPM2 activity has been reported to underlie susceptibility to cell death and biological processes such as inflammatory cell migration and insulin secretion. However, little is known about the intracellular mechanisms that regulate oxidative stress-induced cell death via TRPM2. We report here a molecular and functional interaction between the TRPM2 channel and EF-hand motif-containing protein EFHC1, whose mutation causes juvenile myoclonic epilepsy (JME) via mechanisms including neuronal apoptosis. reversed by JME mutations. These results reveal a positive regulatory action of EFHC1 on TRPM2 activity, suggesting that TRPM2 contributes to the expression of JME phenotypes by mediating disruptive effects of JME mutations of EFHC1 on biological processes including cell death.
Introduction
Mammalian homologues of Drosophila transient receptor potential (TRP) protein form cation channels activated by sensing a variety of physical and chemical stimuli [1, 2] .
TRPM2 is a Ca 2+ -permeable channel activated by ADP-ribose (ADPR) [3, 4] and oxidative stress via -NAD + [5] and/or ADP-ribose [68], and regulated by various factors [911] . TRPM2 activity has been reported to underlie biological processes such as cell death [5] , inflammatory cell migration [8] , and insulin secretion [12] .
Juvenile myoclonic epilepsy (JME) is the most common form of idiopathic generalized epilepsy, accounting for 1030% of all epilepsies [13] . The gene encoding EF-hand motif-containing protein, EFHC1, has been identified in the region on chromosome 6p12-p11 associated with JME [14] . EFHC1 is reported to be expressed in brain neurons [14, 15] , and in ependymal cells of ventricle walls and other cells that possess motile cilia and flagella [1618] . In neuronal cells, EFHC1 increases voltage-dependent R-type Ca 2+ channel (Ca V 2.3) currents and induces neuronal death.
However, the previous report [14] suggests that the EFHC1-dependent Ca V 2.3 Ca 2+ current increase is not an exclusive mechanism that underlies EFHC1-induced neuronal death reversed by the JME mutations. EFHC1 may interact with an additional number of proteins in cell death sensitive to JME mutations. With regard to Ca 2+ channels linked to cell death, TRPM2 has been reported to elicit hydrogen peroxide (H 2 O 2 )-and tumor necrosis factor -induced cell death [5, 19] . Interestingly, reactive oxygen species (ROS) are reported to be constitutively produced in rat hippocampus [20] . The idea that TRPM2 can be the missing protein linking cell death to EFHC1/JME prompted us to test interaction between EFHC1 and TRPM2. Furthermore, it is important to note that genetic disruption of EFHC1 causes enlargement of ventricles and reduced ciliary beating frequency of ependymal cilia in ventricle [21] , and that EFHC1 interacts with microtubules to regulate cell division and cortical development [22] . These recent reports also provide important bases to consider possibilities other than the original scenario focusing on the major role of cell death via R-type Ca 2+ channels in the expression of JME phenotypes.
We show here physical association between EFHC1 and TRPM2. EFHC1 enhanced the H 2 O 2 sensitivity of TRPM2 channel activation and cell death. The obtained results may suggest that EFHC1 regulates voltage-independent TRPM2 Ca 2+ channels to control Ca 2+ homeostasis in neuronal death.
Experimental procedures

Cell Culture and Recombinant Expression in HEK293 Cells
The expression plasmid for human TRPM2 (hTRPM2) was constructed as described previously [5] . HEK293 (ATCC) cells were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS), 30 units/ml penicillin, and 30 g/ml streptomycin. HEK293 cells were co-transfected with pEGFP-EFHC1 or pEGFP-C2 vector and one of pCI-neo-hTRPM2 and the vector pCI-neo. Transfection was carried out using SuperFect Transfection Reagent (QIAGEN). Cells were trypsinized and diluted with DMEM and plated onto glass coverslips 24 h after transfection. Then cells were subjected to measurements 624 h after plating on the coverslips. TRPM2-expressing cells were selected through detection of GFP.
Immunofluorescence Staining
After 24 h of transfection with pcDNA4mycHisA-hTRPM2 and pEGFP-EFHC1 using SuperFect, HEK293 cells were plated onto poly-L-lysine coated glass base dishes (IWAKI, Chiba, Japan). Cells were fixed with 4% paraformaldehyde (PFA), and then permeabilized with 0.1% Triton X-100. The cells were incubated with primary antibody, anti-myc antibody (Invitrogen), followed by subsequent incubation with the Cy3-conjugated anti-mouse secondary antibody. The fluorescence immunoimages were acquired with a confocal laser-scanning microscope (Fluoview 500; Olympus, Tokyo, Japan) equipped with krypton/argon and helium/neon ion lasers. The emitted fluorescence was collected through an objective lens with a 40 times magnification for HEK293 cells.
In Situ Hybridization Histochemistry
For histological staining of the central nervous system (CNS), 8-week-old mice (C57BL/6) were deeply anesthetized with an overdose of Nembutal and then transcardially perfused by 0.9% NaCl, followed by 4% PFA in 0.1 M phosphate buffer (pH 7.4). The brains of the animals were dissected. Cryoprotection of the tissue blocks in 40% sucrose for 24 h at 4°C was followed by histological sectioning on a cryostat (Leica). For details about in situ hybridization histochemistry, see Kagawa et al. [23] .
Briefly, in vitro transcribed DIG-labeled cRNA probe was generated against template EFHC1 cDNA fragment (3191376) of mouse EFHC1 using DIG RNA labeling kit (Roche Applied Science). The probe (0.1 μg/ml) was hybridized overnight to mouse CNS histological 35-μm-thick sections at 50°C. Positive signals were detected by alkaline phosphatase-conjugated anti-digoxigenin antibody and the nitro blue tetrazolium/5-bromo-4-chloro-3'-indolyl phosphate reaction.
Co-immunoprecipitation of TRPM2 and EFHC1 Proteins
Physical interaction between recombinant TRPM2 and EFHC1 was detected by co-immunoprecipitational analysis as previously described [14, 24] . Briefly, FLAG-tagged Ca V 2.3 C-terminus, TRPM2 N-terminus (amino acid residues 1738), TRPM2 C-terminus (10571503), full-length TRPM2, endophilin or EFHC1 was coexpressed with myc-tagged EFHC1 or GFP-tagged EFHC1 in HEK293 cells, and cell lysates were immunoprecipitated by antibody to FLAG (Sigma). Ca V 2.3 C-terminus and endophilin were used as a positive and a negative control for EFHC1, respectively [14] .
Blots were incubated with anti-myc antibody (Santa Cruz Biotechnology) or anti-GFP antibody (Clontech), and stained using Western Lightning Chemiluminescence Reagent Plus (Perkin Elmer Life Sciences).
For characterization of physical interaction between native TRPM2 and EFHC1, mouse brain microsomes were prepared as described previously [24] . Proteins were extracted from the microsomes with RIPA buffer (pH 8.0) containing 0.1% SDS, 0.5% sodium deoxycholate, 1% Nonidet P-40, 150 mM NaCl, 50 mM Tris-HCl, 1 mM PMSF, and 10 g/ml leupeptin, then centrifuged at 17,400 × g for 30 min to remove cell debris.
For coimmunoprecipitation, the cell lysate was incubated with anti-TRPM2 antibody [8] for 2h. Then, the immunocomplexes were incubated with protein A-agarose beads (Santa Cruz) for 1h, and the beads were washed with RIPA buffer. Immunoprecipitated proteins were separated by 10% SDS-PAGE and electrotransferred onto a PVDF membrane. The blots were incubated with anti-EFHC1 monoclonal antibody [17] , and visualized using the ECL system (Thermo Scientific).
In vitro Protein Interaction Studies
We produced the respective proteins of DNA constructs (FLAG-TRPM2 N-terminus, FLAG-TRPM2 C-terminus, FLAG-endophilin and myc-EFHC1) in rabbit reticulolysate by in vitro transcription and translation using Quick Coupled TNT Systems (Promega).
We used 3 g of each plasmid DNA in 50 l of rabbit reticulolysate for translation and incubated for 2 h at 30°C. We then added 50 l of translated myc-EFHC1 rabbit reticulolysate to each of the 50 l rabbit reticulolysate containing translated FLAG-tagged proteins and made the volume up to 500 l with buffer containing 150 mM NaCl, 0.1% Triton X-100 and 50 mM Tris-HCl (pH 7.5). We incubated the mixture for 4 h at 40°C, added anti-myc antibody conjugated to agarose beads (Nacalai Tesque, Kyoto, Japan) and further incubated for 2 h. The beads were washed six times with same buffer and the bound proteins were eluted by adding 40 l of 2×sample buffer followed by boiling for 3 min. The eluted samples were run on 4/20% SDS-PAGE and transferred to nitrocellulose membrane. The membrane was immuno-probed with anti-FLAG antibody conjugated to HRP and stained with ECL-Plus kit (GE healthcare).
Following the first development, the membrane was stripped with Re-Blot Plus buffer (Millipore) and re-immunoprobed with anti-myc antibody. containing 107 mM NaCl, 6 mM KCl, 1.2 mM MgSO 4 , 2 mM CaCl 2 , 11.5 mM glucose, 20 mM HEPES, adjusted to pH 7.4 with NaOH, and applied to the cells by perfusion.
Intracellular Ca
Electrophysiology
Whole-cell currents were recorded at room temperature using the conventional whole-cell configuration [25] . Pipette resistance ranged from 2 to 4 MΩ when filled with the pipette solution described below. 
Statistical analyses
All data are expressed as means ± S.E.. We accumulated the data for each condition from at least three independent experiments. The statistical analyses were performed using the Student's t-test. P values < 0.05 were considered significant.
Results
EFHC1 Physically Associates with TRPM2
To assess the localization of TRPM2 and EFHC1 in brain tissues, in situ hybridization analysis was performed. TRPM2 was expressed in hippocampal pyramidal neurons [5, 26, 27] and ependymal cells in ventricle walls, where EFHC1 was coexpressed as previously reported (Fig. 1A) . The result suggests that TRPM2 and EFHC1 are co-localized in the same cells in the brain. We next examined whether EFHC1 and TRPM2 coexpressed in the same cells are physically associated. Extracts prepared from HEK293 cells transiently expressing EFHC1 plus full-length TRPM2 and from mouse brain microsomes were subjected to co-immunoprecipitation experiments ( Fig. 1B and   1C ). The obtained data suggest protein-protein interaction between TRPM2 and EFHC1.
To identify the interaction site of TRPM2 with EFHC1, extracts prepared from HEK293 cells transiently expressing EFHC1 plus TRPM2 N-or C-terminus were subjected to co-immunoprecipitation experiments. Myc-EFHC1 was co-immunoprecipitated with Ca V 2.3 C-terminus, and TRPM2 N-and C-terminus but not with endophilin [14] (Fig.   1D ). The specificity of the interaction between TRPM2 N-or C-terminus and EFHC1
was also tested using in vitro translated proteins. Myc-tagged EFHC1 brought down FLAG-tagged TRPM2 N-or C-terminus, but not endophillin (Fig 1E) . These results suggest the physical association of EFHC1 with TRPM2 via its putatively cytoplasmic TRPM2 N-and C-terminus. This association is supported by co-immunostaining of TRPM2 and EFHC1 proteins in HEK293 cells. As demonstrated in Fig. 1F , confocal images reveal the subcellular site such as the plasma-membrane area shared by TRPM2
and GFP-EFHC1.
EFHC1 Potentiates TRPM2 Channel Activity in HEK293 Cells
To elucidate the functional impacts of the physical interaction between the EFHC1 and the TRPM2 channel, we examined the effects of EFHC1 Fig. 1 ) [1, 25, 28] .
These results explicitly suggest a functional significance of association between EFHC1
and TRPM2 that positively regulates the activity of TRPM2 channels.
The effect of EFHC1 on ionic currents mediated by TRPM2 induced by ADPR was also examined using a whole-cell mode of patch clamp recording at a holding potential of -60 mV in TRPM2-expressing cells. TRPM2 current was induced by its activation trigger ADPR [3, 4] . In cells expressing EFHC1 and TRPM2, significant inward currents were evoked by ADPR at a concentration of 100 M (3.48 ± 0.09 nA),
while it induced only-marginal inward currents in cells expressing TRPM2 alone (0.56 ± 0.09 nA, P<0.05) (Fig. 2CE) Fig. 2B ). Thus, it is unlikely that EFHC1 is involved in regulation of Ca 2+ sensitivity of TRPM2 channel activation or is influenced by Ca 2+ in TRPM2 interaction.
EFHC1 Facilitates TRPM2-Dependent Cell Death in Response to H 2 O 2
Many reports have indicated that excessive production of ROS is related to neurodegenerative diseases such as Parkinson's disease or amyotrophic lateral sclerosis [32] , while ROS also mediate normal cellular functions [33] . We have previously revealed an important involvement of TRPM2 channels in redox-induced cell death of insulinoma and monocytic cell-lines [5] . The effects of coexpression of EFHC1 protein on H 2 O 2 induced-cell death in TRPM2-expressing HEK293 cells were examined using trypan blue exclusion assay. As shown in Fig. 3 , the percentages of dead cells induced by treatment with 30, 100, and 300 M H 2 O 2 among TRPM2-expressing cells were increased by EFHC1 coexpression (Fig. 3 ). Cell death trigged by H 2 O 2 at these concentrations was abolished in the presence of the anti-oxidant glutathione (1 mM) (data not shown). Thus, EFHC1 enhances cell death mediated by TRPM2 channels.
JME mutations alter the effects of EFHC1 on TRPM2 channel function
In the previous study, we revealed reversing effects of mutations associated with JME on EFHC1 function [14] . However, the cell-death effect of EFHC1 on cultured neurons differed from the enhancing effect of EFHC1 on Ca V 2.3 Ca 2+ currents in susceptibility to suppression by JME mutations: some of the mutations, which nearly abolished the cell-death effect, only weakly suppressed the enhancing effect. Therefore, in reducing EFHC1-mediated neuronal cell death, JME mutations may reverse EFHC1 effects on Ca 2+ signaling-regulating molecules other than Ca V 2.3. Fig. 4A demonstrates a significant reversal of EFHC1-mediated enhancement of H 2 O 2 -induced TRPM2 activity by JME mutations (P77T, D210N, R221H, F229L, and D253Y), but not by coding polymorphisms (R159W, R182H and I619L) that were also present in the control population [14] . Potentiation of ADPR-activated TRPM2 currents was also reversed by the JME mutations but not by coding polymorphisms (Fig. 4B ). EFHC1-induced potentiation of TRPM2-mediated cell death was reversed similarly by the mutations (Fig. 4C ). These data indicate consistency among different modes of experiments with regard to reversal of potentiating effects of EFHC1 by the JME mutations but not by the coding polymorphisms. Importantly, the total amount of TRPM2 protein expression and the amount of TRPM2 protein expression in the surface membrane were indistinguishable, when TRPM2 was expressed with control GFP, wild-type or mutant GFP-EFHC1 constructs (Supplementary Fig. 3 and Supplementary Fig. 4 ). Furthermore,
co-immunoprecipitation experiments revealed that interaction of TRPM2 with EFHC1
is unaffected by JME mutations and polymorphisms ( Supplementary Fig. 5 ). Thus, the efficiency of JME mutations in canceling EFHC1 effects on TRPM2 function corresponds well with the previously reported reversal of neuronal death by the mutations [14] .
Discussion
The present investigation reveals that EFHC1, the candidate gene for JME, physically interacts with the TRPM2 channel, and thereby potentiates the TRPM2 channel activity ] i -dependent regulation of TRPM2 channel activation.
We have previously suggested that EFHC1 increases the Ca V 2.3 Ca 2+ current to enhance neuronal death, which may prevent unwanted hyperexcitable neurons and circuits during the development of the CNS [14] . Reduced Ca V 2.3 activity induced by EFHC1 mutations cannot be an exclusive mechanism that underlies JME, since mice lacking Ca V 2.3 gene display no seizure phenotype [38] . In this study in situ hybridization analysis revealed TRPM2 and EFHC1 were coexpressed in the same cells in hippocampus and ventricles. JME mutations efficiently canceled EFHC1 effects on TRPM2 function. These results suggest that the suppression of H 2 O 2 -activated TRPM2-mediated Ca 2+ influx and cell death by EFHC1 mutations contributes to expression of the JME phenotype. In fact, ROS are reported to be constitutively produced in rat hippocampus [20] .
Previously, it has been demonstrated that genetic disruption of EFHC1 causes enlargement of ventricles and reduced ciliary beating frequency of ependymal cilia in the ventricle [21] , and that EFHC1 interacts with microtubules to regulate cell division [22] . The reports suggest that EFHC1 and its mutations lead to the expression of JME phenotype through processes other than cell death. In this context, it is important to note that TRPM2 is co-expressed with EFHC1 in a variety of tissues including ependima, lung, and testis [5, 16, 17] . TRPM2 may cooperate with EFHC1 in regulation of cellular processes other than cell death in these tissues.
TRPM2 gene has been identified on human chromosome 21q22.3, where genetic disorders such as bipolar affective disorder, nonsyndromic hereditary deafness, Knobloch syndrome, and holoprosencephaly were mapped [26, 39] . Furthermore, in neurons, dysregulation of redox states and intracellular Ca 2+ homeostasis are closely implicated in the pathogenesis of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease or amyotrophic lateral sclerosis [32] . Thus, control of TRPM2 activity by EFHC1 may play an important role in the development and function of the CNS [22] . 
Supplementary Figs
Supplememtary Fig. 2 Katano et al. GFP-EFHC1 (WT) or EFHC1 mutant proteins were detected by western blot analysis using an anti-GFP antibody. Supplementary Fig. 4 Katano et al. Immunoprecipitates with antibody to FLAG are subjected to WB with antibody to GFP. The biotinylation reaction was terminated by washing the cells 3 times with ice-cold PBS containing 10 mM glycine. The cells were then lysed with 300 l of ice-cold RIPA buffer for 30 min at 4C. The cell extracts were cleared by centrifugation and added to 100 l of streptavidin-agarose beads (Pierce) (50% slurry, pre-equilibrated in RIPA buffer) and incubated for 16 h at 4°C. The biotin-streptavidin-agarose complexes were harvested by centrifugation and washed five times with RIPA buffer.
The beads were then resuspended in 2 × sample buffer and incubated at room temperature for 30 min before SDS-PAGE fractionation and Western blotting.
